Yinfeng Institute of Biological Sciences was selected into the first batch of "Provincial New R&D Institutions", accumulating new momentum for industry-university-research collaboration
Release time:
2020-11-18
A few days ago, the Department of Science and Technology of Shandong Province issued the "Announcement on the Preparation of the First Batch of Provincial New R&D Institutions in 2020". Approved to be selected into the first batch of “Provincial New R&D Institutions” in Shandong Province.
This recognition is the first recognition of new R&D institutions in the province. After multiple steps such as unit application, prefecture and city preliminary review, expert demonstration, on-site inspection, conference research, etc., a total of 134 scientific research institutes were selected. Yinfeng Biotechnology The institute is one of the 17 selected scientific research institutes in Jinan City. After inspection, Yinfeng Institute of Biosciences focuses on biomedical technology research and development, and is engaged in gene information database, stem cell technology, cell therapy research and clinical transformation, cryopreservation of human genetic and clinical resources such as human cells, tissues and organs, and even the human body, and maintenance of organ function. The fields of life sciences and other fields have distinctive characteristics and clear directions, and have played an active supporting role in Jinan City’s pilot process of converting old and new growth drivers.
It is reported that in 2019, the Provincial Department of Science and Technology issued the "Interim Measures for the Management of New R&D Institutions in Shandong Province" (Lu Kezi [2019] No. 7), which clearly stated that the construction of new R&D institutions should be comprehensively strengthened, and the province's scientific and technological innovation system should be further improved to provide a basis for the whole province. Providing support for the conversion of old and new kinetic energy. He also pointed out that new R&D institutions mainly refer to independent legal person organizations with diversified investment entities, diversified formation methods, market-oriented operating mechanisms, the ability to achieve sustainable development, and collaborative innovation between industry, academia and research, with the core function of conducting industrial technology research and development, and also It has the functions of applied basic research, technology transfer and transformation, technology enterprise incubation and cultivation, and high-end talent gathering and training.
Yinfeng Institute of Biological Sciences was established in 2015. It is the only comprehensive scientific research unit in Shandong Province that covers the entire industry chain research system of cell tissue resource storage, technology research and product transformation. It now has multiple secondary scientific research units including Hainan Yinfeng Precision Medicine Research Institute, Regenerative Medicine Research Institute, Cryomedicine Research Institute, Gene Technology Research Institute, Immunotherapy Research Institute, Beijing R&D Center, Jinan R&D Center and American R&D Center.
Under the new strategic background of "adhering to the core position of innovation in the overall situation of my country's modernization construction and taking scientific and technological self-reliance and self-reliance as the strategic support for national development", Yinfeng Institute of Biological Sciences will closely follow the needs of economic and social development and scientific and technological development trends, and focus on the overall development of science and technology. Carry out scientific and technological research and development activities on forward-looking technologies, key common technologies, local pillar industries and core technologies of strategic emerging industries in the province's top ten industrial key technology fields, master core technologies, enhance innovation capabilities, empower the development of the medical and health industry, and continue to lead the life sciences Continue to advance with the biotechnology industry to provide stronger and greater scientific and technological support for the implementation of innovation-driven development and the conversion of old and new driving forces.
Next article
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
